{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:03:39Z","timestamp":1780751019849,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ygyno.2024.06.006","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:27:37Z","timestamp":1718825257000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Is pharmacologic venous Thromboprophylaxis necessary for patients undergoing minimally invasive surgery for endometrial Cancer? A systematic review and Meta-analysis"],"prefix":"10.1016","volume":"188","author":[{"given":"Hengxi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2024.06.006_bb0005","doi-asserted-by":"crossref","first-page":"e227S","DOI":"10.1378\/chest.11-2297","article-title":"Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence Based Clinical Practice Guidelines","volume":"141","author":"Gould","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ygyno.2024.06.006_bb0010","article-title":"Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery","volume":"1","author":"Rasmussen","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0015","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ygyno.2021.06.011","article-title":"Postoperative venous thromboembolism in gynecologic oncology patients undergoing minimally invasive surgery: does modality matter?","volume":"162","author":"Wagar","year":"2021","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0020","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/AOG.0000000000001492","article-title":"Clarke-pearson.Venous thromboembolism in minimally invasive compared with open hysterectomy for endometrial cancer","volume":"128","author":"Barber","year":"2016","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.6004\/jnccn.2023.0006","article-title":"Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Rustum","year":"2023","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0030","doi-asserted-by":"crossref","first-page":"790","DOI":"10.14423\/SMJ.0000000000001611","article-title":"Extended venous thromboembolism prophylaxis after robotic staging for endometrial Cancer","volume":"116","author":"Palmieri","year":"2023","journal-title":"South. Med. J."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0035","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Kearon","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.ygyno.2024.06.006_bb0040","author":"National Comprehensive Cancer Network"},{"issue":"2015","key":"10.1016\/j.ygyno.2024.06.006_bb0045","first-page":"654","article-title":"American Society of Clinical Oncology. Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014","volume":"33","author":"Lyman","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdn110","article-title":"ESMO Guidelines Working Group. Management of venous thromboembolism in cancer patients: ESMO clinical recommendations","volume":"19","author":"Mandal\u00e0","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0055","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000004445","article-title":"American College of Obstetricians and Gynecologists' Committee on Practice Bulletins\u2014Gynecology. Prevention of Venous Thromboembolism in Gynecologic Surgery: ACOG Practice Bulletin, Number 232","volume":"138","year":"2021","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0060","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/ijgc-2019-000356","article-title":"Guidelines for perioperative care in gynecologic\/oncology: enhanced recovery after surgery (ERAS) society recommendations-2019 update","volume":"29","author":"Nelson","year":"2019","journal-title":"Int.J. Gynecol.Cancer."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0065","doi-asserted-by":"crossref","unstructured":"D. Moher, L. Shamseer, M. Clarke, D. Ghersi, A. Liberati, M. Petticrew, P. Shekelle, L.A. Stewart, PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement, Syst. Rev. 4(2015):1. doi:https:\/\/doi.org\/10.1186\/2046-4053-4-1.","DOI":"10.1186\/2046-4053-4-1"},{"key":"10.1016\/j.ygyno.2024.06.006_bb0070","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0075","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11701-020-01110-6","article-title":"Incidence of venous thromboembolism after robotic-assisted hysterectomy in obese patients with endometrial cancer: do we need extended prophylaxis?J","volume":"15","author":"Carbajal-Mamani","year":"2021","journal-title":"Robot. Surg."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0080","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.jogc.2018.04.003","article-title":"SOGC communities of practice. Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature","volume":"40","author":"Laskov","year":"2018","journal-title":"J. Obstet. Gynaecol. Can."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0085","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1097\/IGC.0000000000001084","article-title":"Venous thromboembolism in patients receiving extended pharmacologic prophylaxis after robotic surgery for endometrial Cancer","volume":"27","author":"Kim","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2024.06.006_bb0090","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1136\/ijgc-2023-004922","article-title":"Prophylactic anticoagulation after minimally invasive hysterectomy for endometrial cancer: a cost-effectiveness analysis","volume":"33","author":"Bell","year":"2023","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2024.06.006_bb0095","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ygyno.2016.06.002","article-title":"Venous thromboembolism following minimally invasive surgery among women with endometrial cancer","volume":"142","author":"Freeman","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0100","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/AOG.0b013e31826c31fb","article-title":"Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer","volume":"120","author":"Sandadi","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.04.034","article-title":"The limited utility of currently available venous thromboembolism risk assessment tools in gynecological oncology patients","volume":"215","author":"Barber","year":"2016","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0110","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1097\/AOG.0b013e3181f240f7","article-title":"Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery","volume":"116","author":"Nick","year":"2010","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0115","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2016.11.036","article-title":"Prevention of venous thromboembolism in gynecologic oncology surgery","volume":"144","author":"Barber","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2019.07.022","article-title":"Endometrial cancer does not increase the 30-day risk of venous thromboembolism following hysterectomy compared to benign disease. A Danish National Cohort Study","volume":"155","author":"Kahr","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0125","article-title":"Risk of venous thromboembolism following laparoscopic surgery for gynecologic malignancy","author":"Haider","year":"2016","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.ygyno.2024.06.006_bb0130","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.ygyno.2021.06.011","article-title":"Postoperative venous thromboembolism in gynecologic oncology patients undergoing minimally invasive surgery: does modality matter?","volume":"162","author":"Wagar","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"23","key":"10.1016\/j.ygyno.2024.06.006_bb0135","first-page":"02117","article-title":"Risk of thrombosis and bleeding in gynecologic cancer surgery: systematic review and meta-analysis","volume":"S0002-9378","author":"Lavikainen","year":"2023","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824003044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825824003044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:23:22Z","timestamp":1738704202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825824003044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":27,"alternative-id":["S0090825824003044"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.06.006","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is pharmacologic venous Thromboprophylaxis necessary for patients undergoing minimally invasive surgery for endometrial Cancer? A systematic review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2024.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}